Aki Yamamoto

432 total citations
22 papers, 312 citations indexed

About

Aki Yamamoto is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Aki Yamamoto has authored 22 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 6 papers in Biomedical Engineering. Recurrent topics in Aki Yamamoto's work include Extracellular vesicles in disease (5 papers), MicroRNA in disease regulation (5 papers) and RNA Interference and Gene Delivery (2 papers). Aki Yamamoto is often cited by papers focused on Extracellular vesicles in disease (5 papers), MicroRNA in disease regulation (5 papers) and RNA Interference and Gene Delivery (2 papers). Aki Yamamoto collaborates with scholars based in Japan, Taiwan and Denmark. Aki Yamamoto's co-authors include Yoshinobu Takakura, Yuki Takahashi, Yasushi Ishihama, A. Matsumoto, Hsing‐Yi Chang, Yoshinori Sawae, Teruo MURAKAMI, Hiroshi Nakagawa, I Takazoe and Walter Lauriks and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The Journal of the Acoustical Society of America.

In The Last Decade

Aki Yamamoto

21 papers receiving 306 citations

Peers

Aki Yamamoto
Comparison fields: 5 of 81
  • Molecular Biology 180
  • Cancer Research 81
  • Biomedical Engineering 74
  • Surgery 42
  • Immunology 34
Replace Hidehiko Watanabe with:
Hidehiko Watanabe Japan
Y. Negishi Japan
Runze Zhao China
Ruben Daum Germany
Charles S. Wallace United States
Jianhua Jiao China
Ronghan He China
Chaozhong Liu China
Takeru Kondo Japan
Nai‐Wen Liang Taiwan
Hidehiko Watanabe Japan View profile →
Citations per field, relative to Aki Yamamoto
Aki Yamamoto · 1×
Citations per year, relative to Aki Yamamoto
Aki Yamamoto · 1×

Countries citing papers authored by Aki Yamamoto

Since Specialization
Citations

This map shows the geographic impact of Aki Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aki Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aki Yamamoto more than expected).

Fields of papers citing papers by Aki Yamamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aki Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aki Yamamoto. The network helps show where Aki Yamamoto may publish in the future.

Co-authorship network of co-authors of Aki Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Aki Yamamoto. A scholar is included among the top collaborators of Aki Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aki Yamamoto. Aki Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 2
3 5
4 1
5 8
6 12
7 14
8 27
9
[Three Cases of Conversion Surgery for Unresectable Gastric Cancer with Multiple Liver Metastases].
2
10 105
11 16
12 23
13 36
14
Mechanism of elevation in plasma glucagon concentration by soybean protein intake, with reference to changes in the concentration of plasma glucagon-like peptide-1.
1
15
[Clinical evaluation of irinotecan combined with cisplatin by divided administration in patients with untreated primary non-small cell lung cancer].
1
16
Intake of 4-methylumbelliferyl-alpha-glucoside-entrapping liposome into guinea pig macrophages in vivo.
2
17
[Clinical evaluation of enzyme-immunoassay for insulin (author's transl)].
1
18
[Unique crystalline inclusions in monoclonal plasma cells (author's transl)].
1
19
Efficient fractionation of collagenolytic sample from oral bacteroides melaninogenicus.
9
20
Growth promoting effect of corynebacterium upon bacteroides.
5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026